This project was completed by Intensity. Intensity joined Secretariat on February 1, 2023.
A pharmaceutical company was alleged to have misrepresented (false advertising) the medical and health benefits of over-the-counter multivitamin products and doing economic harm to consumers that purchased those products. The claimants sought to certify a class for affected consumers and initiate a class action complaint to recover class wide economic damages.
Intensity was retained to determine an appropriate methodology for certifying the consumer class, and to perform economic analysis related to price premiums on products that were advertised with certain false claims. Intensity evaluated various methodologies for certifying the consumer class and proposed a methodology that was appropriate based on product sales data and consumer demographics.
Intensity also performed an analysis of damages relating to a class action complaint of unfair competition, violation of Consumer’s Legal Remedies Act, and false advertising relating to health products. Intensity estimated damages incurred based on an analysis of the economic effects of the alleged conduct on product sales and profitability.
Economic issues included class certification, price premiums, common class-wide impact, unfair competition, false advertising, and treble damages.
Highlights and Takeaways from CBV CONNECT 2025
At the CBV CONNECT 2025 Conference in Toronto, we had the privilege of presenting multiple panels, engaging with fellow business valuation professionals, and exploring the latest developments shaping the future of the industry. We’ve compiled key takeaways from our time at CONNECT 2025 below, highlighting critical insights from our speaking engagements and the emerging trends […]
56 Secretariat experts were recognized in the Lexology Index 2025 Construction report as leading experts, lauded for their elite expertise, leadership, and client service. 12 of our experts were named as Global Elite Thought Leaders in the report, earning us the No. 1 spot in that category out of more than 650 ranked firms.
Inside RDNA4, Charting Ukraine’s USD 524 Billion Path to Recovery
In this article, Volodymyr Monastyrskyy from Dentons, Chris Richardson and Sulaxmi Rai from Secretariat break down RDNA4’s findings. They discuss where investment is most needed and what it will take to move from damage to development.